ASH24

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

ASH24
Feb 7, 2025, 08:46 | Blog
Latest IACH Post ASH24 webinar dedicated to AML - IACH
IACH shared a post on X: "Now on demand! Our latest IACH Post ASH24 webinar…
Feb 2, 2025, 01:54 | Blog
Reuniting over the most influential research from ASH24
ASH posted on X: "Join us next month in Yokohama, Japan, as hematology professionals from…
Jan 23, 2025, 14:32 | Blog
Amer Zeidan: Insights from the Most Important MDS Studies at ASH24
IACH (International Academy for Clinical Hematology) shared the following on X: “Now available on-demand! Our…
Jan 22, 2025, 08:19 | Blog
Post ASH24: the Most Important CLL Studies - IACH
The International Academy for Clinical Hematology (IACH) posted on X: "Join us TOMORROW for this…
Jan 20, 2025, 16:51 | Blog
Yazan Madanat: Thrilled to present the MDS ASH24 updates at the KU Cancer Center
Yazan Madanat, Leukemia Director and Assistant Professor in the Department of Internal Medicine at UT…
Jan 13, 2025, 17:37 | Blog
The top breakthroughs in multiple myeloma research unveiled at ASH24 - International Myeloma Foundation
International Myeloma Foundation shared a post on X: "The top breakthroughs in multiple myeloma research…
Jan 9, 2025, 12:14 | Blog
Rahul Gosain: Myeloma Highlights with Robert Orlowski from ASH24
Rahul Gosain, Director of Regional Infusion Services and Medical Director at Wilmot Cancer Institute, shared a…
Jan 7, 2025, 17:03 | Blog
Exclusive ASH2024 Insights by Ruben Mesa and Serge Verstovsek - Global MPN Scientific Foundation
Global MPN Scientific Foundation shared a post on X: “Exclusive ASH2024 Insights by Prof. Ruben…
Jan 4, 2025, 06:44 | Insight
Razan Mohty: Cellular therapies for acute leukemia - A Deep Dive from ASH24
Razan Mohty, Assistant Professor at UAB Medicine, shared a post on X: "Cellular therapies for…
Jan 2, 2025, 16:09 | Blog
Save the date for the IACH's Post ASH24 Webinar
IACH shared a post on X: “Save the date for The IACH's Post ASH24 Webinar:…
Dec 27, 2024, 16:42 | Blog
Naveen Pemmaraju: The largest annual meeting in all of hematology blood disorders - ASH24
Naveen Pemmaraju, Professor at the Department of Leukemia at MD Anderson Cancer Center, shared a…
Dec 24, 2024, 11:40 | Blog
Joshua Brody: Practice-changing ASH24 updates on Follicular Lymphoma Immunotherapy
Joshua Brody, Director of Lymphoma Immunotherapy Program at The Icahn School of Medicine at Mount…
Dec 24, 2024, 08:04 | Blog
Registration open for the 2025 Highlights of ASH
ASH shared a post on X: "Join the world's leading hematology experts at Highlights of…
Dec 19, 2024, 08:12 | Insight
Talha Badar: ASH24 abstract in acute leukemia and MDS
Talha Badar, Hematology/Oncology specialist in Mayo Clinic, shared on X: “ASH24 abstract in acute leukemia…
Dec 19, 2024, 07:21 | Insight
Post ASH24: The Most Important MPN Studies - IACH
IACH shared a post on X: “Don’t miss out—happening this FRIDAY IACH Webinar:  Post ASH24:…
Dec 18, 2024, 18:12 | Blog
Divij Verma: The increased risk of pre-leukemic clonal hematopoiesis in 9/11-exposed first responders
Divij Verma, Research Assistant Professor at Albert Einstein College of Medicine, shared a post on…
Dec 17, 2024, 15:40 | Insight
Myeloma Paper of the Day, December 17th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Nice review of the…
Dec 16, 2024, 23:34 | Blog
Mohamad Mohty: Renewed sense of hope and purpose after ASH24
Mohamad Mohty, Chairman of the IACH, shared on X: "One week after the ASH24 annual…
Dec 16, 2024, 18:20 | Insight
Nektar Therapeutics Presented Phase 2 Results for NKTR-255 at ASH 2024
Proof-of-Concept Study Highlights Improved Complete Response Rates and Durability in Relapsed/Refractory Large B-Cell Lymphoma at…
Dec 16, 2024, 18:10 | Insight
Cellenkos Presented Results of Phase 1b Data for CK0804 T-Regulatory Cell Therapy in Myelofibrosis at ASH 2024
Innovative Cellular Therapy Demonstrated Safety and Potential Clinical Benefit at ASH 2024 Cellenkos, a clinical-stage…
Dec 16, 2024, 16:27 | Blog
Uriel Suárez: Highlights of the 66th ASH Annual Meeting and Expo
Uriel Suárez, Resident of hematology at Jiménez Díaz Foundation University Hospital, posted on X: "IACH…
Dec 15, 2024, 18:36 | Blog
More than 65 abstracts and presentations at the 66th ASH Annual Meeting and Exposition by SCRI
Sarah Cannon Research Institute posted on LinkedIn: "And that’s a wrap for ASH24! A standing…
Dec 13, 2024, 23:22 | Blog
Shivani Modi: Grateful for the opportunity to catch up with my mentor Soni Smith at ASH24
Shivani Modi, Resident Physician at Jefferson Health, posted on X: "Grateful for the opportunity to…
Dec 13, 2024, 19:52 | Blog
Supriya Peshin: Congratulations, Sawyer Bawek, on matching at CCF Hematology Oncology Fellows
Supriya Peshin, Internal Medicine Resident at Ballad Health, shared a post on X: "Met at…
Dec 13, 2024, 19:52 | Blog
Supriya Peshin: It’s truly an honor to meet Naveen Pemmaraju
Supriya Peshin, Internal Medicine Resident at Ballad Health, shared a post on X: "Yes, Dr.…
Dec 13, 2024, 19:43 | Blog
Supriya Peshin: Meeting Krisstina Gowin once again has been an absolute highlight
Supriya Peshin, Internal Medicine Resident at Ballad Health, shared a post on X: "Meeting Dr.…
Dec 13, 2024, 18:17 | Blog
Supriya Peshin: I've officially been ASH’d
Supriya Peshin, Internal Medicine Resident at Ballad Health, shared a post on X: "What a…
Dec 13, 2024, 17:07 | Blog
Supriya Peshin: Exceptional opportunity to present my posters at the prestigious ASH24
Supriya Peshin, Internal Medicine Resident at Ballad Health, shared a post on X: "I am…
Dec 13, 2024, 14:07 | Blog
Shivani Modi: Empowering change in Hematology at ASH24
Shivani Modi, Resident Physician at Jefferson Health, shared a post on X: "Empowering change in…
Dec 12, 2024, 19:49 | Blog
Vincent Rajkumar: The Mayo Clinic myeloma group at ASH24
Vincent Rajkumar shared on X: "The Mayo Clinic myeloma group at ASH24 Mayo Myeloma Many…
Dec 12, 2024, 16:42 | Blog
Laura Korin: Gloria Iacoboni on site specific outcomes of CAR-T therapy
Laura Korin, Doctor of the Haematology Service and Unit Of Haematopoietic Transplantation (UTH) of the…
Dec 12, 2024, 14:22 | Blog
Fadi Haddad: Happy to present data on the role of inotuzumab in patients with B-ALL at ASH24
Fadi Haddad, Assistant Professor in the Department of Leukemia at the Division of Cancer Medicine…
Dec 12, 2024, 13:21 | Blog
Shivani Modi: That's a wrap on ASH 2024!
Shivani Modi, Resident Physician at Jefferson Health, posted on X: "That's a wrap on ASH24!…
Dec 12, 2024, 13:11 | Societies
Highlights from Day 4 of 66th ASH Annual Meeting
The 66th ASH Annual Meeting and Exposition was held from December 7-10, 2024, in San…
Dec 12, 2024, 11:16 | Blog
Preclinical data presented at the 66th ASH Annual Meeting - Tessera Therapeutics
Tessera Therapeutics shared a post on LinkedIn: "Today we announced preclinical data presented at the…
Dec 12, 2024, 09:55 | Insight
Jennifer Trowbridge: That's a wrap ASH24
Jennifer Trowbridge, Professor at The Jackson Laboratory, shared a post on X: “That's a wrap…
Dec 11, 2024, 17:41 | Blog
Universal screening for iron deficiency is cost effective and would improve QoL for women - Yale Cancer Center
Yale Cancer Center shared a post on X: "New research from Daniel Wang from Yale School…
Dec 11, 2024, 17:26 | Insight
Fadi Haddad: Congratulations Georgio Medawar on your poster presentations at ASH24
Fadi Haddad, Assistant Professor in the Department of Leukemia at the Division of Cancer Medicine,…
Dec 11, 2024, 17:22 | Blog
Jessica M. Stempel on Aza-Ven +/- Pembro in older AML
Amer Zeidan, Associate Professor of Medicine at Yale University, shared a post on X: "Dr.…
Dec 11, 2024, 14:33 | Blog
Samer Al Hadidi: Oral Myeloma - Majestec-4/EMN30 presented at ASH24
Samer Al Hadidi, Assistant Professor at UAMS Myeloma Center, shared a post on X: "ASH24…
Dec 11, 2024, 14:33 | Blog
The role of ABO matching in stem cell transplant
Nico Gagelmann, Co-chair of EBMT’s Trainee Committee, shared a post on X: "Nailed the talk…
Dec 11, 2024, 14:33 | Blog
Talha Badar: The outcome of TP53m MDS with HMA and VEN vs HMA alone at ASH24
Talha Badar, Hematology/Oncology specialist in Mayo Clinic, shared a post on X: "Great initiative by…
Dec 11, 2024, 12:41 | Blog
Robert Orlowski on patients with newly diagnosed multiple myeloma to benefit from Isa-VRd as initiation therapy
MD Anderson Cancer Center shared on X: "Patients with newly diagnosed multiple myeloma may benefit from…
Dec 11, 2024, 11:27 | Blog
Dr Abdulrahman Alhajahjeh shares cost effectiveness of transplant in intermediate risk AML
Amer Zeidan shared on X: "Dr Abdulrahman Alhajahjeh did an outstanding job to present on behalf…
Dec 11, 2024, 09:53 | Blog
Liso-cel is a feasible and effective option for patients with R/R large B cell lymphoma - MD Anderson Cancer Center
MD Anderson Cancer Center shared a post on X: “For patients with relapsed or refractory…
Dec 11, 2024, 09:45 | Blog
Kelly Meza: Incredible experience with amazing friends and mentors at ASH24
Kelly Meza, Research Assistant at Dana-Farber Cancer Institute, shared a post on X: “What an…
Dec 11, 2024, 09:26 | Blog
Laura Ortiz-Ravick: Proud to have represented The Leukemia and Lymphoma Society at ASH24
Laura Ortiz-Ravick, Director of Outreach and Health Promotion at The Leukemia and Lymphoma Society, shared…
Dec 11, 2024, 09:10 | Insight
Fernando Martín Moro: New drugs in DLBCL frontline
Fernando Martín Moro, Internal Med student at Hematología Salamanca, shared on X: “New drugs in…
Dec 11, 2024, 08:56 | Insight
The AQUILA study from ASH24 is out - IACH
The International Academy for Clinical Hematology (IACH) shared a post on X: “Breaking News: the…
Dec 11, 2024, 08:37 | Opinion
LLS Excellence in Scientific Service awardees Jonathan Licht and Susan O'Brien at ASH24
The Leukemia and Lymphoma Society shared a post on LinkedIn: "Last night at the American…
Dec 11, 2024, 06:37 | Blog
Ruben Mesa: Honored to speak at ASH24 on negotiating your first leadership role
Ruben Mesa, President and Executive Director of Atrium Health Levine Cancer Institute, shared a post…
Dec 11, 2024, 06:31 | Blog
Aaron Goodman: Cilta-cel CART in Smoldering Myeloma
Aaron Goodman, Hematologist/Oncologist and an Associate Professor of Medicine at the University of California, posted the following…
Dec 10, 2024, 23:59 | Blog
Talha Badar: PrECOG 0905 Gilt vs Mido in ND FLT3m AML
Talha Badar, Hematology/Oncology specialist in Mayo Clinic, shared a post on X: "ASH24. PrECOG 0905…
Dec 10, 2024, 19:19 | Blog
Mohamed Benlazar: CPX-351 vs FLAG-Ida in younger adult patients with AML/MDS and MDS-related gene mutations
Mohamed Benlazar, Professor of Hematology at Sidi Bel Abbès University Hospital, shared a post on…
Dec 10, 2024, 19:04 | Blog
Long-term follow-up of the COMMAND presented by Gullermo Garcia-Manero at ASH24
Mohamad Mohty, Professor of Hematology at Sorbonne University and head of the Clinical Hematology and…
Dec 10, 2024, 18:02 | Blog
Welcoming experts at ASH24 - Sarah Cannon Research Institute
Sarah Cannon Research Institute posted the following on LinkedIn: “After a great first day of…
Dec 10, 2024, 14:06 | Blog
Ariela Marshall: ASH24 practice changing abstracts in women's health and children's health in hematology
Ariela Marshall, Chief Innovation Officer at Women in Medicine, posted on X: "ASH24 practice changing…
Dec 10, 2024, 14:00 | Blog
Naveen Pemmaraju: State-of-the-art review of BPDCN
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
Dec 10, 2024, 13:33 | Blog
Rahul Banerjee: Robert Z. Orlowski presented updated IMROZ MRD Multiple Myeloma data
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, posted on X: "ASH24 well, this…
Dec 10, 2024, 12:42 | Blog
The Leukemia and Lymphoma Society Excellence in Scientific Service awardees at ASH24
The Leukemia & Lymphoma Society shared a post on LinkedIn: "Last night at the American…
Dec 10, 2024, 12:21 | Insight
Mohamad Mohty: The breaking news of the day at ASH24
Mohamad Mohty, Professor of Hematology at Sorbonne University and head of the Clinical Hematology and…
Dec 10, 2024, 10:40 | Insight
Highlights from ASH24 Day 2
The 66th ASH Annual Meeting and Exposition, is being held from December 7-10, 2024, in…
Dec 10, 2024, 05:57 | Blog
Ruben Mesa: Discussing approaches to diversify enrollment in cancer clinical trials at ASH24
Ruben Mesa, President and Executive Director of Atrium Health Levine Cancer Institute, shared a post…
Dec 9, 2024, 20:08 | Insight
Kathy Walsh: Phenomenal presentation on Narrative Medicine by Megan Murray Dupuis
Kathy Walsh, Hematologist at Vanderbilt Cancer Center, shared on X: “Phenomenal presentation on Narrative Medicine…
Dec 9, 2024, 20:03 | Insight
Ajay Major: CTCL global QOL scores and pruritis improve in both responders and non-responders
Ajay Major, Assistant Professor of Medicine at the University of Colorado School of Medicine, shared…
Dec 9, 2024, 18:44 | Blog
Supriya Peshin: An extraordinary event hosted by Oncology Brothers
Supriya Peshin, Internal Medicine Resident at Ballad Health, shared a post on X: "What an…
Dec 9, 2024, 15:53 | Blog
Highlights from ASH Annual Meeting 2024 by Naveen Pemmaraju
The 66th ASH Annual Meeting (ASH24) is taking place from December 7-10, 2024, in San…
Dec 9, 2024, 15:42 | Blog
Ruben Mesa: The Advocate Health Hematology Team at ASH24
Ruben Mesa, The President and Executive Director of Atrium Health Levine Cancer Institute, posted on…
Dec 9, 2024, 13:25 | Blog
Rahul Banerjee: The US myeloma immunotherapy consortium has grown
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, shared a post on X: “The…
Dec 8, 2024, 10:53 | Blog
The ASH24 exhibit hall is open
The American Society of Hematology (ASH) shared a post on X: "The ASH24 exhibit hall…
Dec 8, 2024, 10:37 | Blog
"Meet the Expert" sessions at the 2024 ASH Annual Meeting - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: "Exciting News for ASH24 Attendees! The…
Dec 8, 2024, 06:11 | Societies
Highlights from Day 1 of ASH 2024 Annual Meeting and Exposition
The 66th American Society of Hematology (ASH) Annual Meeting and Exposition is being held from…
Dec 8, 2024, 05:58 | Blog
Advancements in Oncology by Oncology Brothers at ASH24
Oncology Brothers shared on X: "At ASH24? Look forward to seeing you tomorrow to discuss…
Dec 8, 2024, 04:20 | Insight
Amer Zeidan: Global Disparities in Characteristics and Outcomes of Leukemia Clinical Trials
Amer Zeidan, Associate Professor of Medicine at Yale University, shared an article by Abdulrahman Alhajahjeh on…
Dec 7, 2024, 13:09 | Blog
Chenyu Lin: Exciting oncology opportunities at Duke Cancer Institute
Chenyu Lin, Assistant Professor of Medicine at Duke University School of Medicine, shared on X:…
Dec 7, 2024, 01:18 | Blog
Payal Desai: Spotlight on curative therapy for sickle cell disease
Payal Desai, Director of Sickle Cell Enterprise, shared the following on LinkedIn: “Excited to present in…
Dec 6, 2024, 10:34 | Blog
Caner Saygin: Proud of the science that our lab will present at ASH24
Caner Saygin, Assistant Professor of Medicine at Division of the Biological Sciences at The University…
Dec 6, 2024, 10:29 | Blog
Mohamad Mohty: Reflections before the start of ASH24
Mohamad Mohty, Professor of Hematology at Sorbonne University and head of the Clinical Hematology and…
Dec 6, 2024, 10:06 | Insight
Joselle Cook: Don’t miss ASH-a-Palooza this Friday in the Gaslamp Quarter
Joselle Cook, Assistant Professor of Medicine at Mayo Clinic, shared an article by Gray Magee…
Dec 5, 2024, 17:07 | Insight
Rahul Banerjee: T-Cell Redirection in AL Amyloidosis - Teclistamab's Success Ahead of ASH24
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, shared a post on X about…
Dec 5, 2024, 16:26 | Insight
Nitin Jain: Update on Pirto Ven and Obin triplet in firstline CLL
Nitin Jain, Professor of Medicine at The University of Texas MD Anderson Cancer Center, shared…
Dec 5, 2024, 16:20 | Insight
ASH24 studies from MD Anderson presented by Jayastu Senapati
Jayastu Senapati, Assistant Professor of Leukemia at MD Anderson Cancer Center, shared on X: “ASH24…
Dec 5, 2024, 16:16 | Insight
Nitin Jain: Relapsed T-ALL remains a very challenging unmet need
Nitin Jain, Professor of Medicine at The University of Texas MD Anderson Cancer Center, shared…
Dec 4, 2024, 20:32 | Insight
Naveen Pemmaraju: Add-On Therapy with CK0804 in Myelofibrosis Patients with Suboptimal Response to Ruxolitinib
Naveen Pemmaraju shared a post on X: "Highlighting the wonderful work of Dr Lucia Masarova. Prelim/early…
Dec 4, 2024, 18:32 | Insight
Naveen Pemmaraju: Temporal dynamics of BM fibrocytes in the progression of primary MF
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
Dec 3, 2024, 18:12 | Insight
Nico Gagelmann: Happy to present first European comparison of cilta-cel vs ide-cel for myeloma at ASH24
Nico Gagelmann, Co-chair of EBMT’s Trainee Committee, shared on X: “Happy to present first European…
Dec 3, 2024, 13:11 | Blog
Ruben Mesa: Honored to join many esteemed colleagues on Hematology’s Leading Experts in 2024 list by MediaMedic
Ruben Mesa, President and Executive Director of Atrium Health Levine Cancer Institute, shared a post…
Dec 2, 2024, 18:18 | Insight
Naveen Pemmaraju: All about RAS pathway mutations in CMML
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
Dec 2, 2024, 18:12 | Insight
Talha Badar: Excited to share my IIT just prior to ASH24
Talha Badar, Hematology/Oncology specialist in Mayo Clinic, shared a post on X: “Very excited to…
Dec 1, 2024, 16:13 | Blog
Vincent Rajkumar: We need more trialists in medicine
Mohamad Mohty, Professor of Hematology at Sorbonne University and Head of the Clinical Hematology and…
Nov 29, 2024, 20:13 | Insight
Joshua Brody: Bispecific antibody immunotherapy for lymphoma
Joshua Brody, Director of Lymphoma Immunotherapy Program at The Icahn School of Medicine at Mount…
Nov 28, 2024, 18:36 | Insight
Ajay Major: The ASH24 Influencers
Ajay Major, Assistant Professor of Medicine at the University of Colorado School of Medicine, shared…
Nov 28, 2024, 17:10 | Opinion
Ajay Major: BAFF-R CAR-T - Promising Outcomes in Refractory B-Cell Lymphomas
Ajay Major, Assistant Professor of Medicine at the University of Colorado School of Medicine, shared…
Nov 21, 2024, 16:11 | Blog
Mike Thompson: Myeloma/Plasma Cell Dyscrasia - Top Abstract Highlights from ASH24
Mike Thompson, Vice President of Clinical Partnerships at Tempus AI, shared a post on X:…
Nov 18, 2024, 12:07 | Blog
Bita Fakhri: Addressing Current Questions and Controversies in the Management of CML
Bita Fakhri, Hematologist/Oncologist at Stanford Department of Medicine, shared a post on X: "If you…
Nov 14, 2024, 15:40 | Blog
Ajay Major: Next-Generation Sequencing (NGS) variants prior to CAR
Ajay Major, Assistant Professor of Medicine at the University of Colorado School of Medicine, posted…
Nov 14, 2024, 15:25 | Insight
Lactic Acidosis to be associated with Early Mortality in Lymphoma Patients
Ajay Major shared a post on X: "Lactic acidosis in lymphomas, ASH24 : - 1259 patientts, 58…
Nov 14, 2024, 12:33 | Insight
Ajay Major: Liso-cel in DLBCL with secondary CNS diagnosis by Jennifer Crombie
Ajay Major, Assistant Professor of Medicine at the University of Colorado School of Medicine, shared…
Nov 10, 2024, 18:49 | Insight
Emma M. Groarke: Our lab will present two telomere biology disorder abstracts at ASH24
Emma M. Groarke, Haematologist at NIH NHLBI, shared a post on X: “Our lab will…
Nov 9, 2024, 15:35 | Blog
Aaron Goodman: 5-year follow-up of POLARIX
Aaron Goodman, Hematologist/Oncologist and an Associate Professor of Medicine at the University of California, shared…
12
All: 112 Posts: 1 - 100
Special Coverage